Sevoflurane Versus Propofol Anesthesia in Intracardiac Echocardiography-Guided Atrial Fibrillation Ablation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 124 participants.

Also called NCT07877116

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose other
Phase
Phase 4
Enrolled
  • 124 participants (planned count) (from the registry)
Sponsor
Hüseyin Ulaş Pinar (from the registry)
Registry
  • NCT NCT07877116
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Türkiye (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07877116. Randomized; single masking; primary purpose other. Start 2026-10-01 (anticipated); primary completion 2027-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sevoflurane Versus Propofol Anesthesia in Intracardiac Echocardiography-Guided Atrial Fibrillation Ablation
Condition
Persistent Atrial Fibrillation
Intervention (Drug)
Sevoflurane
Intervention (Drug)
propofol
Lead sponsor
Hüseyin Ulaş Pinar (class: other)

Record details

Record id
cardio:ct-nct07877116
Content hash
7ac3ab7e6e971fc320d4b8a2e2196b3c16246e425e6dcc15aaf2954b14f13dc4